tiprankstipranks
Trending News
More News >
Merck & Company (DE:6MK)
XETRA:6MK

Compare Merck & Company (6MK) vs. Competitors

Compare
69 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Merck & Company
€99.00
€243.54B
14.46
13.79%
13 Buy
6 Hold
0 Sell
Moderate Buy
Gilead Sciences
$137.21
$170.34B
17.94
29.60%
16 Buy
5 Hold
0 Sell
Strong Buy
Novartis
$146.03
$279.05B
19.02
28.99%
1 Buy
4 Hold
0 Sell
Hold
Pfizer
$26.97
$153.36B
18.21
2.98%
7 Buy
12 Hold
2 Sell
Hold
Sanofi
$44.60
$108.56B
12.88
-22.82%
1 Buy
2 Hold
0 Sell
Moderate Buy
AstraZeneca
13896.00 p
£215.50B
28.13
17.68%
13 Buy
2 Hold
1 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:6MK
Merck & Company
99.00
16.77
20.39%
GILD
Gilead Sciences
137.21
33.24
31.96%
NVS
Novartis
146.03
37.07
34.03%
PFE
Pfizer
26.97
2.60
10.67%
SNY
Sanofi
44.60
-9.60
-17.72%
GB:AZN
AstraZeneca
13,896.00
2,640.17
23.46%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts